This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Anti-SARS-CoV-2 IgG antibodies are associated with reduced viral load
Preprint
in English
| medRxiv
| ID: ppmedrxiv-20110551
ABSTRACT
Anti-SARS-CoV-2 antibodies have been described, but correlation with virologic outcomes is limited. Here, we find anti-SARS-CoV-2 IgG to be associated with reduced viral load. High viral loads were rare in individuals who had seroconverted. Higher viral load on admission was associated with increased 30-day mortality (OR 4.20 [95% CI 1.62-10.86]).
cc_by
Full text:
Available
Collection:
Preprints
Database:
medRxiv
Language:
English
Year:
2020
Document type:
Preprint
